SUMMER 2013 COMPARABILITY STUDY RESULTS AND DISCUSSION

25(OH)DTotal in VitDQAP-II (Vial A), SRM 972a L4 (Vial B), and SRM 968d L1 (Control)
A summary of the individual participant data for 25(OH)DTotal in VitDQAP-II (Vial A), SRM 972a L4 (Vial B), and SRM 968d L1 (Control) is provided in Table 1 .
The community results are summarized at the bottom of Table 1 for all reported methods, the IA methods only, the LC methods only, and the LC-MS n methods only. The community results include the total number of quantitative values reported (N), the median value for each analyte, the MADe (the median absolute deviation estimate, a robust estimate of the standard deviation), and the percent coefficient of variation (CV%). Table 1 also presents the NIST results for the three study materials. For SRM 972a L4 (Vial B), the NIST result is the sum of the certified values for 25(OH)D3 and 25(OH)D2 with the corresponding 95% confidence limits (U95).
The NIST values for 25(OH)D3 in VitDQAP-II (N = 8) and SRM 968d L1 (N = 5) were obtained using an LC-MS/MS reference measurement procedure (RMP) 1 recognized by the Joint Committee for Traceability in Laboratory Medicine (JCTLM). The NIST value for 25(OH)D2 was also obtained using the RMP for VitDQAP-II (N = 5), but for SRM 968d L1 the value was well below the limit of quantitation and was estimated to be 0.1 ng/mL (N = 1). The NIST values for 25(OH)DTotal in VitDQAP-II (Vial A) and SRM 968d L1 (Control) reported in Table 1 are the sum of the individual values for 25(OH)D3 and 25(OH)D2, and the 95% confidence limit (U95) incorporates the uncertainties for the two analytes and includes components for measurement variability and measurement uncertainty associated with the density of the materials.
For SRM 968d L1 (Control), the participants were provided the NIST target values within the data reporting sheet so that they could qualify their methods prior to analyzing the study samples. From the single reported values for all LC datasets for a given technique (IA or LC), the consensus median and the consensus variability (2  MADe) were determined. For both of the major techniques (IA or LC) in each figure, the solid lines () and () represent the consensus median, and the dashed lines (-----) and (-----) represent the approximate 95% confidence interval (2  MADe). The laboratories with results that fall between the two dashed lines are within the consensus variability area for their technique (IA or LC).
The red lines () in each figure (Figures 1 -3 ) represent the NIST value and its associated uncertainty (i.e., value ± U95). NIST believes that the "true" value for each material lies within this interval. When these lines are not within the consensus range, then there may be method bias.
Specific results for each of the three study materials are summarized below: CLIA) .  For the LC results, the consensus variability range is very large, and there are no outliers.  The consensus median value for the IA results agrees well with the NIST expanded uncertainty range (red lines).  The consensus median value for the LC results is considerably higher (80%) than both the IA median value and the NIST expanded uncertainty range (red lines).  The NIST expanded uncertainty range (red lines) falls within the consensus variability ranges for both IA and LC results. VitDQAP-II (Vial A) also has a significant 3-epi-25(OH)D3 concentration of 3.4 ng/mL ± 0.1 ng/mL, or ≈ 9% of the 25(OH)D3 concentration of 37.0 ng/mL ± 0.4 ng/mL (NIST values). In theory, bimodal results should have also been obtained for this material, but the 9% bias is indistinguishable in the overall method variability of 12% for the LC results.
Of the nine LC participants that used methods that separate the 3-epi-25(OH)D3, seven reported values for this metabolite in the control and study materials. The LC method results for 25(OH)D3 and 3-epi-25(OH)D3 are presented and discussed in detail later in this report. 190 191 192 193 194 195 196 197 198 199 190 191 192 193 194 195 196 197 198 199 190 191 192 193 194 195 196 197 198 199 , and B) SRM 972a L4 (Vial B) and SRM 968d L1 (Control). In each plot, there are two blue consensus boxes, one for IA methods and one for LC methods (as indicated). Laboratory results that are within the consensus range for both study materials are within the blue consensus boxes. Conversely, laboratory results that fall outside of (or on the edge of) either of the consensus boxes are not included in the consensus ranges and are highlighted with their laboratory code numbers. In each plot, the NIST values for the materials are denoted with a red diamond symbol (), and the Youden line (y=x) centered on the NIST value is illustrated by a red line () across the magnitude of the y-axis and x-axis, respectively.
Specific results as assessed from the Youden comparison plots are summarized below. Figure 4 A  Laboratory results that are not included in the consensus ranges include numbers 110, 128, 200, 210b, 213a, 222 , and 247a  The Youden line runs through the center of the IA consensus box and through the bottom corner of the LC consensus box for these materials, illustrating that the IA results are in better agreement with the NIST results for these materials.  Most of the LC results for SRM 972a L4 are higher than both the Youden line and the IA consensus box; however, the LC box overlaps both the Youden line and the IA consensus box because the LC consensus box is very large in the SRM 972a L4 dimension (y-axis).
VitDQAP-II (Vial A) and SRM 972a L4 (Vial B):
SRM 972a L4 (Vial B) and SRM 968d L1 (Control): Figure 4 B
 Laboratory results that are not included in the consensus ranges include numbers 116, 119, 139, 196, 198c, 210a, 211, 213a, 221a, 241 , and 255  The Youden line runs through the center of the IA consensus box and through the left corner of the LC consensus box for these materials, illustrating that the IA results are in better agreement with the NIST results for these materials.  Most of the LC results for SRM 972a L4 are higher than both the Youden line and the IA consensus box; however, the LC box overlaps both the Youden line and the IA consensus box because the LC consensus box is very large in the SRM 972a L4 dimension (x-axis).
Both of these Youden plots involving SRM 972a L4 (Vial B) reveal separation of the IA results and the majority of the LC results, further illustrating the difference in results for the two techniques for the material with high levels of 3-epi-25(OH)D3. In the Summer 2013 comparability study, all but one of the LC participants reported values for 25(OH)D3, and the reported values are summarized in Table 2 .
Of the 33 LC participants, nine used methods that separated the 3-epi-25(OH)D3 interference from 25(OH)D3 (Appendix A-2, A-3). Of those nine, seven participants reported values for 3-epi-25(OH)D3 in the study samples and in the control, and the results are summarized in Table 3 .
For both Table 2 and Table 3 , the community results are summarized at the bottom of the table for all LC methods and for the LC-MS n methods only. These summarized results include N, the median value, the MADe, and the CV%. Table 2 and Table 3 also present the NIST values and the 95% confidence limits (U95) for 25(OH)D3 and 3-epi-25(OH)D3, respectively, in the study and control materials.
For the participant results for SRM 972a L4 (Vial B), the consensus variability is large for 25(OH)D3 (30%). The source of the measurement uncertainty for 25(OH)D3 is the wideranging, bimodal results from labs that separate the 3-epi-25(OH)D3 and those that do not. However, the results for the seven participants that measure 3-epi-25(OH)D3 exhibit relatively low variability for VitDQAP-II (Vial A) and SRM 972a L4 (Vial B) with a CV ≈ 8%. Figure 5 and Figure 6 present direct graphical comparisons of the LC results for 25(OH)D3 and 3-epi-25(OH)D3, respectively, for A) VitDQAP-II (Vial A) and SRM 972a L4 (Vial B), and B) SRM 972a L4 (Vial B) and SRM 968d L1 (Control). In each plot, there is one blue consensus box for the LC results. Laboratory results that are within the consensus range for both study materials are within the blue consensus box. Conversely, laboratory results that fall outside of (or on the edge of) the consensus box are not included in the consensus range and are highlighted with their laboratory code numbers. In each plot, the NIST values for the materials are denoted with a red diamond symbol (), and the Youden line (y=x) centered on the NIST value is illustrated by a red line () across the magnitude of the y-axis and x-axis, respectively.
Specific results as assessed from the Youden comparison plots are summarized below. Figure 5 A  Laboratory results that are not included in the consensus range include numbers 110 and 128.  The Youden line runs through the cluster of LC results that separate the 25(OH)D3 and 3-epi-25(OH)D3, illustrating the better agreement of these results with the NIST values for these materials.  Most of the LC results for SRM 972a L4 are higher than the Youden line; however, the Youden line overlaps the bottom of the LC consensus box, which is very large in the SRM 297a L4 dimension (y-axis). Figure 6 B  Only three of the laboratory results are included in the consensus range for these materials because of the variability of the results for SRM 968d L1 (y-axis).  The Youden line runs through the center of the consensus box, indicating good agreement of the LC results with the NIST values for these materials even with the higher variability of results for SRM 968d L1 (y-axis). 
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Conclusions from the Summer 2013 Comparability Study of the VitDQAP
In the six previous comparability studies of the VitDQAP, participant performance was consistent for study materials that contain predominantly 25(OH)D3; the CV was in the range from 7% to 19%, and the median values were biased slightly high relative to the NIST values. In the Summer 2013 comparability study, both VitDQAP-II (Vial A) and SRM 968d L1 (Control) also contain predominantly 25(OH)D3. The participant results for VitDQAP-II (Vial A) and SRM 968d L1 (Control) had a CV of 12% and 7%, respectively, and the all-method median values were biased slightly high relative to the NIST values, indicating the performance for these two materials is comparable to similar materials previously evaluated in the VitDQAP.
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